World's Best Scientists 2026 revealed!

D-Index & Metrics

Chemistry

D-Index
60
Citations
13519
World Ranking
9654
National Ranking
286

Felix Kratz publication distribution in Chemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Chemistry in 2026. The highlighted bar marks where Felix Kratz sits on this spectrum.

61–80 publications: 66 scientists 81–100 publications: 302 scientists 101–120 publications: 623 scientists 121–140 publications: 918 scientists 141–160 publications: 1,218 scientists 161–180 publications: 1,350 scientists 181–200 publications: 1,344 scientists 201–220 publications: 1,281 scientists 221–240 publications: 1,216 scientists 241–260 publications: 1,100 scientists 261–280 publications: 979 scientists 281–300 publications: 939 scientists 301–320 publications: 764 scientists 321–340 publications: 643 scientists 341–360 publications: 628 scientists 361–380 publications: 522 scientists 381–400 publications: 459 scientists 401–420 publications: 397 scientists 421–440 publications: 327 scientists 441–460 publications: 270 scientists 461–480 publications: 265 scientists 481–500 publications: 252 scientists 501–520 publications: 201 scientists 521–540 publications: 185 scientists 541–560 publications: 148 scientists 561–580 publications: 148 scientists 581–600 publications: 132 scientists 601–620 publications: 114 scientists 621–640 publications: 104 scientists 641–660 publications: 91 scientists 661–680 publications: 92 scientists 681–700 publications: 73 scientists 701–720 publications: 57 scientists 721–740 publications: 54 scientists 741–760 publications: 67 scientists 761–780 publications: 45 scientists 781–800 publications: 46 scientists 801–820 publications: 39 scientists 821–840 publications: 32 scientists 841–860 publications: 36 scientists 861–880 publications: 29 scientists 881–900 publications: 26 scientists 901–920 publications: 24 scientists 921–940 publications: 14 scientists 941–960 publications: 23 scientists 961–980 publications: 28 scientists 981–1,000 publications: 15 scientists 1,001–1,020 publications: 29 scientists 1,021–1,040 publications: 12 scientists 1,041–1,060 publications: 19 scientists 1,061–1,080 publications: 12 scientists 1,081–1,100 publications: 6 scientists 1,101–1,120 publications: 8 scientists 1,121–1,140 publications: 12 scientists 1,141–1,160 publications: 5 scientists 1,161–1,180 publications: 6 scientists 1,181–1,200 publications: 14 scientists 1,201–1,220 publications: 7 scientists 1,221–1,240 publications: 2 scientists 1,241–1,260 publications: 6 scientists 1,261–1,280 publications: 4 scientists 1,281–1,294 publications: 6 scientists 1,295+ publications: 100 scientists
61 publications 1,295+

This scientist: 156 publications — 16th percentile

16% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,295 publications or more.

Felix Kratz D-index placement in Chemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Chemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Felix Kratz sits on this spectrum.

40–41 D-Index: 289 scientists 42–43 D-Index: 612 scientists 44–45 D-Index: 808 scientists 46–47 D-Index: 776 scientists 48–49 D-Index: 835 scientists 50–51 D-Index: 861 scientists 52–53 D-Index: 872 scientists 54–55 D-Index: 933 scientists 56–57 D-Index: 1,051 scientists 58–59 D-Index: 930 scientists 60–61 D-Index: 882 scientists 62–63 D-Index: 834 scientists 64–65 D-Index: 731 scientists 66–67 D-Index: 775 scientists 68–69 D-Index: 683 scientists 70–71 D-Index: 646 scientists 72–73 D-Index: 561 scientists 74–75 D-Index: 501 scientists 76–77 D-Index: 437 scientists 78–79 D-Index: 388 scientists 80–81 D-Index: 354 scientists 82–83 D-Index: 292 scientists 84–85 D-Index: 275 scientists 86–87 D-Index: 254 scientists 88–89 D-Index: 235 scientists 90–91 D-Index: 185 scientists 92–93 D-Index: 192 scientists 94–95 D-Index: 155 scientists 96–97 D-Index: 163 scientists 98–99 D-Index: 125 scientists 100–101 D-Index: 105 scientists 102–103 D-Index: 105 scientists 104–105 D-Index: 112 scientists 106–107 D-Index: 88 scientists 108–109 D-Index: 68 scientists 110–111 D-Index: 69 scientists 112–113 D-Index: 65 scientists 114–115 D-Index: 79 scientists 116–117 D-Index: 61 scientists 118–119 D-Index: 44 scientists 120–121 D-Index: 37 scientists 122–123 D-Index: 40 scientists 124–125 D-Index: 33 scientists 126–127 D-Index: 26 scientists 128–129 D-Index: 34 scientists 130–131 D-Index: 35 scientists 132–133 D-Index: 25 scientists 134–135 D-Index: 27 scientists 136–137 D-Index: 17 scientists 138–139 D-Index: 16 scientists 140–141 D-Index: 20 scientists 142–143 D-Index: 20 scientists 144–145 D-Index: 15 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 9 scientists 150–151 D-Index: 16 scientists 152–153 D-Index: 11 scientists 154–155 D-Index: 9 scientists 156–157 D-Index: 3 scientists 158 D-Index: 3 scientists 159+ D-Index: 98 scientists
40 D-Index 159+

This scientist: 60 D-Index — 47th percentile

47% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 159 D-Index or more.

Overview

Felix Kratz is affiliated with the University of Florence in Italy and has contributed to research primarily in the fields of Engineering and Biochemistry, Genetics, and Molecular Biology. Their work extends into subfields such as Biomedical Engineering, Condensed Matter Physics, Pulmonary and Respiratory Medicine, Cell Biology, and Biophysics.

Their research covers a range of topics, including:

  • Microfluidic and Bio-sensing Technologies
  • Micro and Nano Robotics
  • Molecular Communication and Nanonetworks
  • Cellular Mechanics and Interactions
  • Cell Image Analysis Techniques
  • 3D Printing in Biomedical Research
  • Connective Tissue Disorders Research

Kratz has published regularly in several scientific venues. The most frequent publication venues include:

  • Biophysical Journal
  • Soft Matter
  • bioRxiv (Cold Spring Harbor Laboratory)
  • International Journal of Molecular Sciences
  • Langmuir

Notable recent publications by Felix Kratz include:

  • Enhancing robustness, precision, and speed of traction force microscopy with machine learning, 2023, Biophysical Journal
  • Chemotactic migration of bacteria in porous media, 2021, Biophysical Journal
  • Cell-Penetrating Doxorubicin Released from Elastin-Like Polypeptide Kills Doxorubicin-Resistant Cancer Cells in In Vitro Study, 2021, International Journal of Molecular Sciences
  • Pressure-deformation relations of elasto-capillary drops (droploons) on capillaries, 2021, Soft Matter
  • Chemotactic Migration of Bacteria in Porous Media, 2020, bioRxiv (Cold Spring Harbor Laboratory)

Frequent co-authors collaborating with Kratz include:

  • Jan Kierfeld
  • Sujit S. Datta
  • Tapomoy Bhattacharjee
  • Daniel B. Amchin
  • Jenna Ott

Best Publications

  • Albumin as a drug carrier: Design of prodrugs, drug conjugates and nanoparticles

    Unknown

  • Polymer Therapeutics: Concepts and Applications

    Rainer Haag;Felix Kratz

  • Impact of albumin on drug delivery — New applications on the horizon

    Unknown

  • Prodrug strategies in anticancer chemotherapy.

    Felix Kratz;Ivonne A. Müller;Claudia Ryppa;André Warnecke

  • Probing the Cysteine-34 Position of Endogenous Serum Albumin with Thiol-Binding Doxorubicin Derivatives. Improved Efficacy of an Acid-Sensitive Doxorubicin Derivative with Specific Albumin-Binding Properties Compared to That of the Parent Compound

    Felix Kratz;André Warnecke;Karin Scheuermann;Cornelia Stockmar

  • A clinical update of using albumin as a drug vehicle — A commentary

    Felix Kratz

  • Clinical impact of serum proteins on drug delivery

    Unknown

  • Drug-polymer conjugates containing acid-cleavable bonds.

    Felix Kratz;Ulrich Beyer;Mark Thomas Schutte

  • A new approach for the treatment of malignant melanoma: enhanced antitumor efficacy of an albumin-binding doxorubicin prodrug that is cleaved by matrix metalloproteinase 2.

    Ahmed M. Mansour;Joachim Drevs;Norbert Esser;Farid M. Hamada

  • Transferrin Conjugates of Doxorubicin: Synthesis, Characterization, Cellular Uptake, and in Vitro Efficacy

    Felix Kratz;Ulrich Beyer;Thomas Roth;Nadya Tarasova

  • Serum proteins as drug carriers of anticancer agents: a review.

    Felix Kratz;Ulrich Beyer

  • A novel macromolecular prodrug concept exploiting endogenous serum albumin as a drug carrier for cancer chemotherapy.

    Felix Kratz;Ralph Müller-Driver;Inga Hofmann;Joachim Drevs

  • A facile approach for dual-responsive prodrug nanogels based on dendritic polyglycerols with minimal leaching

    Xuejiao Zhang;Katharina Achazi;Dirk Steinhilber;Felix Kratz

  • Finding the optimal balance: Challenges of improving conventional cancer chemotherapy using suitable combinations with nano-sized drug delivery systems

    Felix Kratz;André Warnecke

  • Binding of ruthenium(III) anti-tumor drugs to human lactoferrin probed by high resolution X-ray crystallographic structure analyses

    Clyde A. Smith;Andrew J. Sutherland-Smith;Felix Kratz;E. N. Baker

  • Albumin-binding prodrugs of camptothecin and doxorubicin with an Ala-Leu-Ala-Leu-linker that are cleaved by cathepsin B: synthesis and antitumor efficacy.

    Björn Schmid;Da-Eun Chung;André Warnecke;Iduna Fichtner

  • DOXO-EMCH (INNO-206): the first albumin-binding prodrug of doxorubicin to enter clinical trials

    Unknown

  • Acid-sensitive polyethylene glycol conjugates of doxorubicin: preparation, in vitro efficacy and intracellular distribution

    Paula C.A. Rodrigues;Ulrich Beyer;Peter Schumacher;Thomas Roth

  • Polyethylene glycol conjugates of methotrexate varying in their molecular weight from MW 750 to MW 40000: synthesis, characterization, and structure-activity relationships in vitro and in vivo

    Katja Riebeseel;Elfi Biedermann;Roland Löser;Norbert Breiter

  • Development of efficient acid cleavable multifunctional prodrugs derived from dendritic polyglycerol with a poly(ethylene glycol) shell

    Marcelo Calderón;Pia Welker;Kai Licha;Iduna Fichtner

  • Maleimide-oligo(ethylene glycol) derivatives of camptothecin as albumin-binding prodrugs: synthesis and antitumor efficacy.

    André Warnecke;Felix Kratz

  • Development of Novel Bisphosphonate Prodrugs of Doxorubicin for Targeting Bone Metastases That Are Cleaved pH Dependently or by Cathepsin B: Synthesis, Cleavage Properties, and Binding Properties to Hydroxyapatite As Well As Bone Matrix

    Katrin Hochdörffer;Khalid Abu Ajaj;Cynthia Schäfer-Obodozie;Felix Kratz

  • Development of enzymatically cleavable prodrugs derived from dendritic polyglycerol.

    Marcelo Calderón;Ralph Graeser;Felix Kratz;Rainer Haag

  • Development and in vitro efficacy of novel MMP2 and MMP9 specific doxorubicin albumin conjugates

    Felix Kratz;Joachim Drevs;Gerlinde Bing;Cornelia Stockmar

  • Development of pH-responsive core–shell nanocarriers for delivery of therapeutic and diagnostic agents

    Shangjie Xu;Ying Luo;Ralph Graeser;André Warnecke

  • Prodrug Strategies in Anticancer Chemotherapy

    Felix Kratz;Ivonne A. Mueller;Claudia Ryppa;Andre Warnecke

Frequent Co-Authors

Rainer Haag
Rainer Haag Freie Universität Berlin
Marcelo Calderón
Marcelo Calderón University of the Basque Country
Rolf Mülhaupt
Rolf Mülhaupt University of Freiburg
Luigi Messori
Luigi Messori University of Florence
Irmgard Merfort
Irmgard Merfort University of Freiburg
Bernhard K. Keppler
Bernhard K. Keppler University of Vienna
Manfred Jung
Manfred Jung University of Freiburg
Kurt E. Geckeler
Kurt E. Geckeler Gwangju Institute of Science and Technology
Annette G. Beck-Sickinger
Annette G. Beck-Sickinger Leipzig University
Barbara Rothen-Rutishauser
Barbara Rothen-Rutishauser University of Fribourg

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Chemistry in the USA opens up diverse career options, often complemented by related fields such as criminal justice, paralegal studies, and pharmaceutical sales. Many students explore affordable options for education, making it important to consider factors like criminal justice degree tuition when budgeting for related online programs.

For those interested in starting with foundational education, an online associates in criminal justice can offer a practical step. This credential provides valuable skills that can complement scientific qualifications, especially in regulatory or compliance roles involving chemistry.

Another promising avenue is paralegal work, which often intersects with patent law and chemical regulations. Understanding what types of paralegals make the most money can guide chemistry graduates toward lucrative specialties that support legal cases in pharmaceutical or chemical industries.

Finally, the pharmaceutical industry offers rewarding positions such as pharmaceutical sales representatives. Learning more about the pharmaceutical sales rep salary and career pathways can help Chemistry graduates leverage their technical knowledge in a client-facing role with strong earning potential.

Best Scientists Citing Felix Kratz

Trending Scientists

Recently Published Articles